Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|August 9, 2003
Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancerMartin J Heslin, Jieming Yan, Heidi Weiss, et al.
Genome Biology|January 8, 2021
An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processesSaba Ghaffari, Casey Hanson, Remington E Schmidt, et al.
Genome Biology|August 3, 2023
BEDwARS: a robust Bayesian approach to bulk gene expression deconvolution with noisy reference signaturesSaba Ghaffari, Kelly J Bouchonville, Ehsan Saleh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinomaHarry H Yoon, Mark A Lewis, Qian Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial)Dan Sha, Adam M Lee, Qian Shi, et al.
Molecular Carcinogenesis|April 1, 2005
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7William M Boedefeld, Richie Soong, Heidi Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracilLori K Mattison, Jeanne Fourie, Yukihiro Hirao, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 20, 2012
A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)Erin M Bertino, Tanios Bekaii-Saab, Soledad Fernandez, et al.
Pageof 10